Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Antibodies, Monoclonal, Humanized »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antibodies, Monoclonal < Antibodies, Monoclonal, Humanized < Antibodies, Monoclonal, Murine-Derived  Facettes :

List of bibliographic references indexed by Antibodies, Monoclonal, Humanized

Number of relevant bibliographic references: 1791.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000003 (2020) Charlotte Girard-Guyonvarc'H ; Michele Iudici[Targeted therapies for connective tissue diseases and vasculitis].
000011 (2020) Binqing Fu ; Xiaoling Xu ; Haiming WeiWhy tocilizumab could be an effective treatment for severe COVID-19?
000012 (2020) Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis]When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety.
000075 (2020) Anca D. Askanase [États-Unis] ; Leila Khalili [États-Unis] ; Jill P. Buyon [États-Unis]Thoughts on COVID-19 and autoimmune diseases
000149 (2020) Emre Bilgin [Oman] ; Rem Ozarli [Turquie] ; Levent K L Ç [Turquie] ; Ertu Rul Ça R Bölek [Turquie] ; Gözde Kübra Yard Mc [Turquie] ; Ömer Karada [Turquie]Some concerns from Turkey.
000190 (2020) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Some concerns from Turkey' by Bilgin et al.
000197 (2020) Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000245 (2020) Ana Luisa Oliveira [Portugal] ; Carina Ruano [Portugal] ; Nuno Riso [Portugal] ; José Cepeda Ribeiro [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]Paradoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumonia.
000258 (2020) Peter N. Taylor [Royaume-Uni] ; Lei Zhang [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Ilaria Muller [Royaume-Uni] ; Daniel G. Ezra [Royaume-Uni] ; Colin M. Dayan [Royaume-Uni] ; George J. Kahaly [Allemagne] ; Marian Ludgate [Royaume-Uni]New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000351 (2020) Etienne Dufranc [France] ; Arnaud Del Bello [France] ; Julie Belliere [France] ; Nassim Kamar [France] ; Stanislas Faguer [France]IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
000355 (2020) Heidi LedfordHow does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.
000381 (2020) Xuhan Zhang [République populaire de Chine] ; Kaidi Song [République populaire de Chine] ; Fei Tong [République populaire de Chine] ; Mingming Fei [République populaire de Chine] ; Hui Guo [République populaire de Chine] ; Zhaohui Lu [République populaire de Chine] ; Jinquan Wang [République populaire de Chine] ; Changcheng Zheng [République populaire de Chine]First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
000415 (2020) Tomoyuki Asano ; Shuzo Sato ; Jumpei Temmoku ; Yuya Fujita ; Makiko Yashiro Furuya ; Naoki Matsuoka ; Hiroko Kobayashi ; Eiji Suzuki [Japon] ; Hiroshi Watanabe ; Kiyoshi MigitaEffectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis
000437 (2020) Catalina Sanchez-Alvarez [États-Unis] ; Matthew Koster [États-Unis] ; Ali Duarte-García [États-Unis] ; Kenneth J. Warrington [États-Unis]Disease progression of Takayasu arteritis in two patients treated with tocilizumab.
000494 (2020) Naoto Sakumura [Japon] ; Hitoshi Irabu [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Masaki Shimizu [Japon]Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab.
000521 (2020) Jon T. Giles [États-Unis] ; Naveed Sattar [Royaume-Uni] ; Sherine Gabriel [États-Unis] ; Paul M. Ridker [États-Unis] ; Steffen Gay [Suisse] ; Charles Warne [Royaume-Uni] ; David Musselman [États-Unis] ; Laura Brockwell [Royaume-Uni] ; Emma Shittu [Royaume-Uni] ; Micki Klearman [États-Unis] ; Thomas R. Fleming [États-Unis]Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.
000544 (2020) Carina Mihai [Suisse] ; Rucsandra Dobrota [Suisse] ; Maria Schröder [Suisse] ; Alexandru Garaiman [Suisse] ; Suzana Jordan [Suisse] ; Mike Oliver Becker [Suisse] ; Britta Maurer [Suisse] ; Oliver Distler [Suisse]COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
000582 (2020) Franco Maria Buonaguro [Italie] ; Igor Puzanov [États-Unis] ; Paolo Antonio Ascierto [Italie]Anti-IL6R role in treatment of COVID-19-related ARDS
000586 (2020) Tomohiro Koga ; Naoko Hagimori [Japon] ; Shuntaro Sato [Japon] ; Shinpei Morimoto [Japon] ; Naoki Hosogaya [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi KawakamiAn open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance
000613 (2020) Bernhard Hellmich [Allemagne] ; Ana Agueda [Portugal] ; Sara Monti [Italie] ; Frank Buttgereit [Allemagne] ; Hubert De Boysson [France] ; Elisabeth Brouwer [Pays-Bas] ; Rebecca Cassie [Royaume-Uni] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Autriche] ; Gulen Hatemi [Turquie] ; Nicole Hollinger [Allemagne] ; Alfred Mahr [France] ; Susan P. Mollan [Royaume-Uni] ; Chetan Mukhtyar [Royaume-Uni] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Rajappa Sivakumar [Inde] ; Xinping Tian [République populaire de Chine] ; Gunnar Tomasson [Islande] ; Carl Turesson [Suède] ; Wolfgang Schmidt [Allemagne] ; Peter M. Villiger [Suisse] ; Richard Watts [Royaume-Uni] ; Chris Young [Royaume-Uni] ; Raashid Ahmed Luqmani [Royaume-Uni]2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
000614 (2020) Haneul Kim [Corée du Sud] ; Seungye Baek [Corée du Sud] ; Seung-Min Hong [Corée du Sud] ; Jaeseon Lee [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jennifer Lee [Corée du Sud] ; Mi-La Cho [Corée du Sud] ; Seung-Ki Kwok [Corée du Sud] ; Sung-Hwan Park [Corée du Sud]1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis
000626 (2019) Claudia Dechant [Allemagne] ; Hendrik Schulze-Koops [Allemagne][Update Giant Cell Arteriitis].
000627 (2019) Maxime Samson [France] ; Hélène Greigert [France] ; Thibault Ghesquière [France] ; Bernard Bonnotte [France][Treatment of giant cell arteritis].
000628 (2019) F. Frikha [Tunisie] ; S. Garbaa [Tunisie] ; Y. Bouattour [Tunisie] ; M. Snoussi [Tunisie] ; H. Loukil [Tunisie] ; R. Ben Salah [Tunisie] ; Z. Bahloul [Tunisie][Tocilizumab for refractory Takayasu arteritis with aortic aneurysm].
000629 (2019) Zaira Cubiles Arillo [Espagne] ; Esmeralda Nú Ez Cuadros [Espagne] ; Ver Nica Martínez Rivera [Espagne] ; José Manuel González G Mez [Espagne] ; Victorio Cuenca Peir [Espagne][Takayasu arteritis of atypical presentation. Tocilizumab as an alternative therapeutic option].
000631 (2019) P M Villiger [Suisse][Large-vessel vasculitis-giant cell and Takayasu arteritis].
000632 (2019) H. Liao [République populaire de Chine] ; L L Pan ; J. Du ; N. Gao ; T. Wang[Efficacy and safety of tocilizumab in patients with Takayasu arteritis].
000643 (2019) C B Bunker [Royaume-Uni] ; J. Manson [Royaume-Uni]Vitiligo remitting with tocilizumab.
000654 (2019) Bartlomiej Wawrzycki [Pologne] ; Dorota Krasowska [Pologne] ; Aldona Pietrzak [Pologne] ; Ewa Wielosz [Pologne] ; Maria Majdan [Pologne] ; Torello Lotti [Italie]Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
000671 (2019) Markus Breu [Autriche] ; Sarah Glatter [Autriche] ; Romana Höftberger [Autriche] ; Michael Freilinger [Autriche] ; Karl Kircher [Autriche] ; Gregor Kasprian [Autriche] ; Rainer Seidl [Autriche] ; Barbara Kornek [Autriche]Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab.
000677 (2019) Nienke M. Ter Haar ; E. H. Pieter Van Dijkhuizen ; Joost F. Swart ; Annet Van Royen-Kerkhof ; Ayman El Idrissi ; Arjen P. Leek ; Wilco De Jager ; Mark C. H. De Groot ; Saskia Haitjema ; Dirk Holzinger ; Dirk Foell ; Jorg Van Loosdregt ; Nico M. Wulffraat ; Sytze De Roock ; Sebastiaan J. VastertTreatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study
000682 (2019) Sisi Cai ; Zhaodong Zhong ; Xiang Li [République populaire de Chine] ; Hong Xiang Wang [République populaire de Chine] ; Li Wang [République populaire de Chine] ; Min ZhangTreatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids
000683 (2019) Miguel González-Gay [Afrique du Sud] ; Trinitario Pina [Espagne] ; Diana Prieto-Pe A [Espagne] ; M Nica Calderon-Goercke [Espagne] ; Oreste Gualillo [Espagne] ; Santos Casta Eda [Espagne]Treatment of giant cell arteritis.
000695 (2019) Michitaro Hayakawa [Japon] ; Keisuke Izumi [Japon] ; Misako Higashida-Konishi [Japon] ; Mari Ushikubo [Japon] ; Masako Tsukamoto [Japon] ; Kumiko Akiya [Japon] ; Kazuhiro Araki [Japon] ; Hisaji Oshima [Japon]Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.
000699 (2019) Helen Hayward-Koennecke [Autriche] ; Markus Reindl [Autriche] ; Roland Martin [Autriche] ; Sven Schippling [Autriche]Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis.
000700 (2019) Martin Krusche [Allemagne] ; Nikolas Ruffer [Allemagne] ; Ina Kötter [Allemagne]Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature.
000704 (2019) Kentaro Chino [Japon] ; Tsuneo Kondo [Japon] ; Ryota Sakai [Japon] ; Shuntaro Saito [Japon] ; Yusuke Okada [Japon] ; Akiko Shibata [Japon] ; Takahiko Kurasawa [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Koichi Amano [Japon]Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.
000706 (2019) Martina Biggioggero [Oman] ; Chiara Crotti [Italie] ; Andrea Becciolini [Oman] ; Ennio Giulio Favalli [Oman]Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
000708 (2019) Young Ho Lee [Corée du Sud]Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment.
000709 (2019) M Nica Calder N-Goercke [Espagne] ; Javier Loricera [Espagne] ; Vicente Aldasoro [Espagne] ; Santos Casta Eda [Espagne] ; Ignacio Villa [Espagne] ; Alicia Humbría [Espagne] ; Clara Moriano [Espagne] ; Susana Romero-Yuste [Espagne] ; Javier Narváez [Espagne] ; Catalina G Mez-Arango [Espagne] ; Eva Pérez-Pampín [Espagne] ; Rafael Melero [Espagne] ; Elena Becerra-Fernández [Espagne] ; Marcelino Revenga [Espagne] ; Noelia Álvarez-Rivas [Espagne] ; Carles Galisteo [Espagne] ; Francisca Sivera [Espagne] ; Alejandro Olivé-Marqués [Espagne] ; María Álvarez Del Buergo [Espagne] ; Luisa Marena-Rojas [Espagne] ; Carlos Fernández-L Pez [Espagne] ; Francisco Navarro [Espagne] ; Enrique Raya [Espagne] ; Eva Galindez-Agirregoikoa [Espagne] ; Beatriz Arca [Espagne] ; Roser Solans-Laqué [Espagne] ; Arantxa Conesa [Espagne] ; Cristina Hidalgo [Espagne] ; Carlos Vázquez [Espagne] ; José Andrés Román-Ivorra [Espagne] ; Pau Lluch [Espagne] ; Sara Manrique-Arija [Espagne] ; Paloma Vela [Espagne] ; Eugenio De Miguel [Espagne] ; Carmen Torres-Martín [Espagne] ; Juan Carlos Nieto [Espagne] ; Carmen Ordas-Calvo [Espagne] ; Eva Salgado-Pérez [Espagne] ; Cristina Luna-Gomez [Espagne] ; F Javier Toyos-Sáenz De Miera [Espagne] ; Nagore Fernández-Llanio [Espagne] ; Antonio García [Espagne] ; Carmen Larena [Espagne] ; Natalia Palmou-Fontana [Espagne] ; Vanesa Calvo-Río [Espagne] ; Diana Prieto-Pe A [Espagne] ; Carmen González-Vela [Espagne] ; Alfonso Corrales [Espagne] ; María Varela-García [Espagne] ; Elena Aurrecoechea [Espagne] ; Raquel Dos Santos [Espagne] ; Ángel García-Manzanares [Espagne] ; Norberto Ortego [Espagne] ; Sabela Fernández [Espagne] ; Francisco Ortiz-Sanjuán [Espagne] ; Montserrat Corteguera [Espagne] ; José L. Hernández [Espagne] ; Miguel González-Gay [Espagne] ; Ricardo Blanco [Espagne]Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
000710 (2019) G. Novi [Italie] ; M. Gastaldi [Italie] ; D. Franciotta [Italie] ; G. Pesce [Italie] ; L. Benedetti [Italie] ; A. Uccelli [Italie]Tocilizumab in MOG-antibody spectrum disorder: a case report.
000713 (2019) Alex Ganetsky [États-Unis] ; Noelle V. Frey [États-Unis] ; Elizabeth O. Hexner [États-Unis] ; Alison W. Loren [États-Unis] ; Saar I. Gill [États-Unis] ; Selina M. Luger [États-Unis] ; James K. Mangan [États-Unis] ; Mary Ellen Martin [États-Unis] ; Daria V. Babushok [États-Unis] ; William R. Drobyski [États-Unis] ; Jacqueline Smith [États-Unis] ; Colleen Timlin [États-Unis] ; Craig W. Freyer [États-Unis] ; Edward A. Stadtmauer [États-Unis] ; David L. Porter [États-Unis]Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
000715 (2019) Santos Casta Eda [Espagne] ; Dolores Martínez-Quintanilla [Espagne] ; José L. Martín-Varillas [Espagne] ; Noelia García-Casta Eda [Espagne] ; Belén Atienza-Mateo [Espagne] ; Miguel A. González-Gay [Espagne]Tocilizumab for the treatment of adult-onset Still's disease.
000716 (2019) Chipman Rg Stroud [États-Unis] ; Aparna Hegde [États-Unis] ; Cynthia Cherry [États-Unis] ; Abdul R. Naqash [États-Unis] ; Nitika Sharma [États-Unis] ; Srikala Addepalli [États-Unis] ; Sulochana Cherukuri [États-Unis] ; Teresa Parent [États-Unis] ; Jessica Hardin [États-Unis] ; Paul Walker [États-Unis]Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
000718 (2019) Valeria Dipasquale [Italie] ; Marco Atteritano [Italie] ; Jlenia Fresta [Italie] ; Irene Castagna [Italie] ; Giovanni Conti [Italie]Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases.
000719 (2019) Kazutoshi Ebisawa [Japon] ; Yosuke Masamoto [Japon] ; Junji Tokushige [Japon] ; Hiroshi Nishi [Japon] ; Kenjiro Honda [Japon] ; Munetoshi Hinata [Japon] ; Kazuhiro Toyama [Japon] ; Masaomi Nangaku [Japon] ; Mineo Kurokawa [Japon]Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.
000721 (2019) Jumpei Saito ; Naho Yakuwa ; Kayoko Kaneko [Japon] ; Chinatsu Takai ; Mikako Goto ; Ken Nakajima ; Akimasa Yamatani ; Atsuko MurashimaTocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum.
000723 (2019) Fenglong Xie [Royaume-Uni] ; Huifeng Yun [Royaume-Uni] ; Emily B. Levitan [Royaume-Uni] ; Paul Muntner [Royaume-Uni] ; Jeffrey R. Curtis [Royaume-Uni]Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients.
000724 (2019) Levente Bodoki [Hongrie] ; Edit Végh [Hongrie] ; Zoltán Szekanecz [Hongrie] ; Gabriella Sz Cs [Hongrie]Tocilizumab Treatment in Polyarteritis Nodosa.
000728 (2019) Liyang Gu [Oman] ; Shuang YeTocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Antibodies, Monoclonal, Humanized" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Antibodies, Monoclonal, Humanized" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Antibodies, Monoclonal, Humanized
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021